A pharma giant is moving past one patent cliff — but another is already looming
Source:
cnbc
October 29, 2026 · 23:00
From the publisher
Disappointing data highlights Novartis' challenge to build its next generation of blockbuster medicines, following a series of clinical trial setbacks.
About the source
CNBC
The Consumer News and Business Channel (CNBC) is an American business news channel owned by Versant. The network broadcasts live business news and analysis programming during the morning, daytime business day, and early-evening hours, with the remaining hours filled by business-related documentaries and reality television programming, as well as occasional sports presentations from USA Sports. CNBC operates an accompanying financial news website, CNBC.com, which includes news articles, video and…
Wikidata Q1023912
Wikidata ↗
The original article opens on the publisher's website.
More from General
View topic →Binance hacker dumps a little-known 2017 token and it crashes 90%
coinDesk
Oct 30, 2026 · 00:54
Bitcoin, ether and XRP selloff wipes out $1.5 billion in leveraged crypto bets
coinDesk
Oct 29, 2026 · 23:22
XRP Ledger developers tighten the rules for who can hold 'restricted' tokens
coinDesk
Oct 29, 2026 · 22:45
Binance hack bites India's largest crypto exchange as it curbs futures trading
coinDesk
Oct 29, 2026 · 22:43
Binance hacker splits $1.4 billion of bitcoin into 19 wallets that no one can freeze
coinDesk
Oct 29, 2026 · 21:50